Loading...

Bio-Techne Corporation

TECH•NASDAQ
Healthcare
Biotechnology
$54.19
$1.99(3.81%)
U.S. Market opens in 49h 27m

Bio-Techne Corporation (TECH) Stock Overview

Explore Bio-Techne Corporation’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap8.5B
P/E Ratio104.30
EPS (TTM)$0.53
ROE0.04%
Fundamental Analysis

AI Price Forecasts

1 Month$42.78
3 Months$50.12
1 Year Target$52.86

TECH Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Bio-Techne Corporation (TECH) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 44.91, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $52.86.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 104.30 and a market capitalization of 8.5B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
3.81%
5-Day Change
-7.35%
1-Month Change
3.36%
3-Month Change
-20.50%
6-Month Change
-17.78%
Year-to-Date (YTD) Change
-7.86%
1-Year Change
6.72%
3-Year Change
-35.56%
5-Year Change
-50.80%
All-Time (Max) Change
49442.88%

Contact Information

https://www.bio-techne.com
612 379 8854
614 McKinley Place N.E., Minneapolis, MN, 55413

Company Facts

3,100 Employees
IPO DateFeb 9, 1989
CountryUS
Actively Trading

Frequently Asked Questions